Article

ForbesForbes on 2019-12-04 19:30

Why Has Alnylam’s Stock Gained 25% In The Last Two Weeks

Alnylam (NASDAQ: ALNY) is a U.S.-based biopharma company primarily developing RNA interference drugs. The company recently announced that the USFDA ...

Related news